Form 4: Annexon Director Acquires Stock Options

Annexon, Inc. director William H. Carson acquired 65,000 stock options with an exercise price of $4.70, vesting under specific service conditions.

Summary

• William H. Carson, a director at Annexon, Inc., was granted 65,000 stock options on June 11, 2026.
• The options have an exercise price of $4.70 per share.
• These options are subject to vesting conditions tied to the reporting person's continuous service as a director.
• Vesting occurs on the earlier of the first anniversary of June 11, 2026, or the next Annual Meeting following that date.
• The underlying shares are common stock of Annexon, Inc. (ANNX).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard grant of stock options to a director, which is a routine event and does not inherently signal positive or negative performance.

Positives

• Director William H. Carson has been granted stock options, indicating a potential alignment of management interests with shareholder value.
• The grant of options suggests confidence in the company's future prospects, as the value of the options increases with the stock price.

Negatives

• The options are subject to vesting, meaning the director does not immediately own the underlying shares and must remain with the company to realize their full value.

Risks

• The value of the stock options is directly tied to the future performance of Annexon, Inc.'s stock price, which is subject to market volatility and company-specific risks.
• The vesting schedule introduces a risk of forfeiture if the reporting person's continuous service as a director is not maintained.

Future Outlook

The vesting of the stock options is contingent on the reporting person's continuous service as a director, with full vesting occurring on the earlier of the first anniversary of June 11, 2026, or the next Annual Meeting following that date.

Industry Context

StockSavvy.ai notes that the issuance of stock options to directors is a common practice in the biotechnology and pharmaceutical sectors, aiming to incentivize long-term performance and align executive interests with those of shareholders. Annexon, Inc. operates in this space, and such grants are standard for attracting and retaining key leadership.

Stakeholder Impact

• Shareholders: The grant of options to a director can be viewed positively as it aligns the director's financial interests with the company's stock performance, potentially leading to decisions that benefit shareholders.
• Employees: While not directly impacted, the retention of experienced directors can contribute to stable leadership and strategic direction, indirectly benefiting employees.
• Management: The director receives potential future financial benefit tied to the company's success.

Next Steps

• Reporting Person to maintain continuous service as a director until the vesting date.
• Vesting of 100% of the stock options on the earlier of the first anniversary of June 11, 2026, or the next Annual Meeting following June 11, 2026.

Key Dates

Keywords

Annexon Inc., ANNX, Form 4, Stock Options, Director Compensation, Beneficial Ownership, SEC Filing, William H. Carson